Quick Hits: Wal-Mart Will Take a Check
Brief scrutiny of today's headlines
Because of clever initiatives like cheap meal solutions and the continuation of their low-cost prescription drug program. According to Bloomberg, Wal-Mart has expanded its prescription drug deals, offering pharmaceuticals for $4 a month or three months for $10, forcing Target (TGT) to create similar discounts. It's also offering to cash economic stimulus checks in-store free of charge.
The National Retail Federation says consumers plan to spend 40% of their stimulus checks, but are now more likely to spend them on food and gas than when the program was first announced in February. Still, by offering to cash those checks, Wal-Mart ensures a captive audience. Who can resist low prices with free cash in hand?
Standard & Poor's Retail Index dropped an average of 21% last year, while Wal-Mart posted a 22% increase. According to the Fox Business Channel, Wal-Mart reported Tuesday that their profits rose 6.9% in the first quarter. Earnings were at $3.02 billion, or 76 cents per share, in the three months leading up to April 30th. With numbers like these, maybe Wal-Mart should be the one sending out stimulus checks.
The company is expanding outside the U.S. to compensate for domestic slowdown and to maintain its competitive edge, building new stores from Brazil to China. According to Market Watch, Wal-Mart's control of inventory helps alleviate the need for unnecessary sales and promotions and saves it money. This keeps retail prices down so cost-conscious consumers can feed their families, while also feeding the Bentonville giant.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter